Evaluation of adenosine deaminase (ADA) isoenzymes activity and tumor necrosis factor-alpha (TNFalpha) concentration in chronic heart failure

Simple item page
dc.contributor.authorKhodadadi, Iraj
dc.contributor.authorVahedi, Mohammad Saleh
dc.contributor.authorAbdi, Mohammad
dc.contributor.authorDaneshkhah, Nasrin
dc.contributor.authorRahbari, Rezgar
dc.contributor.authorMenbari, Shahoo
dc.contributor.authorAhmadi, Dara
dc.contributor.authorAhmadi, Abbas
dc.contributor.authorLahoorpour, Fariba
dc.contributor.authorHakhamaneshi, Mohammad Saied
dc.contributor.authorJavid, Saman
dc.contributor.authorNikkhoo, Bahram
dc.date.accessioned2014-05-13T11:43:12Z
dc.date.available2014-05-13T11:43:12Z
dc.date.issued2014-02-03
dc.description.abstractChronic heart failure (CHF) has recently been considered as an inflammatory disease. Enhanced production of tumor necrosis factor-α (TNFα) in CHF patients has been proved. To compensate deleterious effects of TNFα, the concentration of adenosine is increased in CHF. However, concurrent determination of serum TNFα and enzymatic activities of ADA and its ADA1 and ADA2 isoenzymes, as the main regulators of adenosine concentration, has not yet been carried out. Materials and Methods: Blood samples were collected from 52 CHF patients and 55 healthy controls. Laboratory routine tests were performed, and after determining the concentration of TNFα, total ADA (tADA) as well as ADA1 and ADA2 isoenzyme activities were measured. Results: Mean concentration of TNFα increased over 2-fold in CHF patients (12.54± 11.69 pg/ml compared with 6.0± 6.58 pg/ml in controls). The highest level of TNFα was observed in patients with the final stage of the disease (NHYA-IV subgroup), according to the New York Heart Association classification. tADA activity was significantly lower in CHF patients compared with controls (19.29 ± 9.73 and 24.3 ± 6.01 U/L, respectively). ADA2 activity markedly decreased in CHF patients and showed a direct correlation with tADA (r = 0.641, P = 0001). In addition, the lowest levels of tADA and ADA2 activities were observed in patients from the 4th quartile of NYHA classification. Conclusion: Adenosine deaminase activity is reduced in CHF patients to give rise to the concentration of adenosine, thereby attenuating pathologic consequences of CHF. Therefore, it is concluded that ADA activity is of paramount importance in pathophysiology of heart failure and might be used for diagnostic purposes or treatment targets.en
dc.identifier.issn1611-2156
dc.identifier.urihttp://hdl.handle.net/2003/33124
dc.identifier.urihttp://dx.doi.org/10.17877/DE290R-15479
dc.language.isoen
dc.relation.ispartofseriesEXCLI Journal ; Vol. 13, 2014en
dc.subjectadenosine deaminaseen
dc.subjectheart failureen
dc.subjectisoenzymesen
dc.subjecttumor necrosis factor-alphaen
dc.subject.ddc610
dc.titleEvaluation of adenosine deaminase (ADA) isoenzymes activity and tumor necrosis factor-alpha (TNFalpha) concentration in chronic heart failureen
dc.typeText
dc.type.publicationtypearticle
dcterms.accessRightsopen access
eldorado.dnb.zdberstkatid2132560-1

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Abdi_03022014_proof.pdf
Size:
219.73 KB
Format:
Adobe Portable Document Format
Description:
DNB
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.85 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Original Articles